ACRIA was the first organization to recognize that the new, highly effective medications developed in the mid-1990s would allow people with HIV to live far longer than was ever thought possible, even into older age. It soon became clear that we were entering a new phase of the epidemic where HIV was a manageable—although serious—chronic illness. Knowing that a significant shift in services and policies would need to take place to address this, ACRIA launched its seminal Research on Older Adults with HIV (ROAH) study in 2006 to investigate this unique population and what kind of support they required. When it was released, this widely cited study was the first, largest, and most comprehensive one of its kind.
More than a decade later, ACRIA embarked on an ambitious follow-up to the first ROAH study. The newly formed ACRIA Center for HIV and Aging at GMHC launched ROAH 2.0 and issued its first report, focusing on the epidemic in San Francisco, in October 2018. The full ROAH 2.0 study will also include nearly 3,000 older adults living with HIV in sites across the country including New York City, Upstate New York, Chicago, and Alameda County (CA).
ROAH 2.0
